{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:28:25Z","timestamp":1790947705099,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.vaccine.2010.08.017","type":"journal-article","created":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T09:02:05Z","timestamp":1281776525000},"page":"7047-7053","source":"Crossref","is-referenced-by-count":74,"title":["Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1"],"prefix":"10.1016","volume":"28","author":[{"given":"Pascal Feunou","family":"Feunou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Kammoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Debrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Mielcarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Locht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.08.017_bib0005","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1473-3099(02)00452-8","article-title":"Pertussis of adults and infants","volume":"2","author":"Von K\u00f6nig","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1473-3099(03)00669-8","article-title":"How best to estimate the global burden of pertussis?","volume":"3","author":"Crowcroft","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2010.08.017_bib0015","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1097\/01.inf.0000166154.47013.47","article-title":"Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination","volume":"24","author":"Edwards","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0020","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1542\/peds.2005-2746","article-title":"Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age","volume":"118","author":"Gustafsson","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0025","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0264-410X(98)00040-1","article-title":"Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines","volume":"16","author":"Salmaso","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1086\/516293","article-title":"Prevalence of markers of exposure to Bordetella pertussis among Italian young adults","volume":"26","author":"Rota","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0035","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0022-3476(98)70395-6","article-title":"Antibody responses and persistence in the two years after immunization with two acellular and one whole cell vaccine against pertussis","volume":"132","author":"Giuliano","year":"1998","journal-title":"J Pediatrics"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0040","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/S0264-410X(03)00407-9","article-title":"Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis","volume":"21","author":"Storsaeter","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0045","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0264-410X(02)00777-6","article-title":"Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine","volume":"21","author":"Olin","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0050","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1086\/315527","article-title":"Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children","volume":"181","author":"Mahon","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0055","doi-asserted-by":"crossref","first-page":"e1000647","DOI":"10.1371\/journal.ppat.1000647","article-title":"Estimating the duration of pertussis immunity using epidemiological signatures","volume":"5","author":"Wearing","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0060","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1371\/journal.ppat.0020065","article-title":"Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough","volume":"2","author":"Mielcarek","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0065","doi-asserted-by":"crossref","first-page":"e10178","DOI":"10.1371\/journal.pone.0010178","article-title":"T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis","volume":"5","author":"Feunou","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0070","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1016\/j.vaccine.2008.08.018","article-title":"Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1","volume":"26","author":"Feunou","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0075","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1128\/IAI.62.3.769-778.1994","article-title":"Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis","volume":"62","author":"Menozzi","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0080","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/IAI.58.6.1518-1526.1990","article-title":"Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin","volume":"58","author":"Antoine","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0085","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1002\/j.1460-2075.1992.tb05394.x","article-title":"Common accessory genes for the Bordetella pertussis filamentous hemagglutinin and fimbrae share sequence similarities with the papC and papD gene families","volume":"11","author":"Locht","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.1998.00401.x","article-title":"Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children","volume":"48","author":"Ryan","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0095","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.vaccine.2006.10.048","article-title":"Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life","volume":"25","author":"Guiso","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0100","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1128\/IAI.67.8.4064-4071.1999","article-title":"Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines","volume":"67","author":"Ausiello","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0105","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1086\/315509","article-title":"Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine","volume":"60","author":"Ausiello","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0110","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0115","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1286-4579(01)01421-6","article-title":"Immunity to Bordetella pertussis","volume":"3","author":"Mills","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/CVI.00322-09","article-title":"Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice","volume":"17","author":"Mielcarek","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"Pulendran","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0130","first-page":"955","article-title":"Placebo-controlled trial of two acellular pertussis vaccines in Sweden\u2014protective efficacy and adverse events","volume":"1","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0135","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses","volume":"181","author":"Cherry","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0882-4010(91)90038-C","article-title":"Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonization","volume":"11","author":"Guiso","year":"1991","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0150","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/IAI.61.2.399-410.1993","article-title":"Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"Mills","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.08.017_bib0155","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1128\/IAI.61.8.3190-3198.1993","article-title":"Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity","volume":"61","author":"Redhead","year":"1993","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T13:11:22Z","timestamp":1591794682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10011266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":31,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0264410X10011266"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}